• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 filed by Afya Limited

    11/12/25 5:26:20 PM ET
    $AFYA
    Other Consumer Services
    Real Estate
    Get the next $AFYA alert in real time by email
    S-8 1 dp237260_s8.htm FORM S-8

     

    As filed with the Securities and Exchange Commission on November 12, 2025

    Registration No. 333-       

     

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

    FORM S-8

     

    REGISTRATION STATEMENT
    UNDER
    THE SECURITIES ACT OF 1933

     

    AFYA LIMITED
    (Exact Name of Registrant as Specified in Its Charter)

     

    The Cayman Islands
    (State or Other Jurisdiction of
    Incorporation or Organization)
    N/A
    (I.R.S. Employer
    Identification No.)

     

    Rua Paraíba, No. 330, 17º Andar, CEP 30130-917
    Bairro Funcionários, Belo Horizonte, Minas Gerais
    +55 (31) 3515 7550
    (Address, including zip code, and telephone number, including area code, of Registrant’s principal executive offices)

     

    Amended and Restated Stock Option Plan of Afya Limited
    Restricted Stock Plan of Afya Ltd.
    (Full Title of the Plan)

     

    Cogency Global Inc.
    122 East 42nd Street, 18th Floor
    New York, NY 10168
    +1 (212) 947-7200 


    (Name, address and telephone number,
    including area code, of agent for service)

     

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

     

    Large accelerated filer ☒ Accelerated filer ☐
    Non-accelerated filer ☐ (Do not check if a smaller reporting company) Smaller reporting company ☐
      Emerging Growth Company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

     

     

     

     

     

    EXPLANATORY NOTE

     

    Pursuant to General Instruction E to Form S-8, this Registration Statement on Form S-8 (the “Registration Statement”) is being filed for the purpose of registering an additional 3,393,220 Class A common shares, par value $0.00005 per share (“Shares”), of Afya Limited (the “Registrant”) authorized for issuance pursuant to the Registrant’s Amended and Restated Stock Option Plan (the “Plan”) and an additional 987,016 Shares authorized for issuance pursuant to the Registrant’s Restricted Stock Plan. This Registration Statement hereby incorporates by reference the contents of the registration statements on Form S-8 (File Nos. 333-268884 and 333-268886) previously filed by the Registrant on December 19, 2022.

     

    PART II

     

    INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

     

    Item 3.  Incorporation of Documents by Reference

     

    The following documents previously filed with the Securities and Exchange Commission (“Commission”) are incorporated herein by reference:

     

    (a)   The Annual Report on Form 20-F for the Registrant for the year ended December 31, 2024, filed with the Commission on April 29, 2025 (Registration No. 001-38992) (the “2024 Form 20-F”).

     

    (b)   All other reports filed by the Registrant pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) since December 31, 2024.

     

    (c)   The description of the Registrant’s Class A common shares contained in the Registrant’s 2024 Form 20-F.

     

    In addition, all documents subsequently filed by the Registrant pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act (with respect to any Form 6-K, only to the extent designated therein), prior to the filing of a post-effective amendment to this Registration Statement which indicates that all securities offered have been sold or which deregisters all securities then remaining unsold, including any Reports of Foreign Private Issuers on Form 6-K submitted during such period (or portion thereof), shall be deemed to be incorporated by reference in this Registration Statement and to be a part hereof from the date of the filing of such documents. The Registrant is not incorporating by reference any documents or portions thereof, whether specifically listed above or filed in the future, that are not deemed “filed” with the Commission.

     

    Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein (or in any other subsequently filed document which also is incorporated or deemed to be incorporated by reference herein), modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.

     

     

     

    Item 8.  Exhibits

     

    Exhibit
    Number
       
    4.1*   Amended and Restated Memorandum and Articles of Association of the Registrant (incorporated by reference to Exhibit 1.4 of the Registrant’s Annual Report on Form 20-F (File No. 001-38992) filed with the Commission on April 28, 2023)
    5.1   Opinion of Maples and Calder (Cayman) LLP
    23.1   Consent of Ernst & Young Auditores Independentes S.S. Ltda,
    23.2   Consent of Maples and Calder (Cayman) LLP (included in Exhibit 5.1)
    24.1   Power of Attorney (included on the signature pages of this Registration Statement)
    99.1   Amended and Restated Stock Option Plan of Afya Limited (filed herewith)
    99.2   Restricted Stock Plan of Afya Ltd.
    107   Calculation of filing fee table

     

    *Incorporated herein by reference

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Belo Horizonte, Brazil, on November 12, 2025.

     

      AFYA LIMITED
       
       
      By: /s/ Virgilio Deloy Capobianco Gibbon
      Name: Virgilio Deloy Capobianco Gibbon
      Title: Chief Executive Officer
        (Principal Executive Officer)

     

     

     

    POWER OF ATTORNEY

     

    The undersigned directors and officers of Afya Limited  hereby constitute and appoint Virgilio Deloy Capobianco Gibbon and Luis André Blanco, and each of them, individually, as attorneys-in-fact and agents for the undersigned, with full power of substitution for, and in the name, place and stead of the undersigned, to sign and file with the Securities and Exchange Commission under the Securities Act of 1933, any and all amendments (including post-effective amendments) and exhibits to this registration statement on Form S-8 (or any other registration statement for the same offering that is to be effective upon filing pursuant to Rule 462(b) under the Securities Act of 1933) and any and all applications and other documents to be filed with the Securities and Exchange Commission pertaining to the registration of the securities covered hereby, each with full power and authority to do and perform any and all acts and things whatsoever requisite and necessary or desirable, hereby ratifying and confirming all that said attorneys-in-fact and agents or any of them, or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

     

    Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.

     

    Signature 

     

    Title 

     

    Date 

    /s/ Virgilio Deloy Capobianco Gibbon

      Chief Executive Officer
    (Principal Executive Officer)
      November 12, 2025
    Virgilio Deloy Capobianco Gibbon        
             
             

    /s/ Luis André Blanco

      Chief Financial Officer
    (Principal Financial Officer and Principal Accounting Officer)
      November 12, 2025
    Luis André Blanco        
             
             

    /s/ Nicolau Carvalho Esteves

      Co-Chairman of the Board   November 12, 2025
    Nicolau Carvalho Esteves        
             
             

    /s/ Kay Krafft

      Co-Chairman of the Board   November 12, 2025
    Kay Krafft        
             
             

    /s/ Benedikt Dalkmann

      Director   November 12, 2025
    Benedikt Dalkmann        
             
             
    /s/ Christina Krebs   Director   November 12, 2025
    Christina Krebs        
             
             
    /s/ Renato Tavares Esteves   Director   November 12, 2025
    Renato Tavares Esteves        
             

    /s/ Maria Tereza Azevedo

      Director   November 12, 2025
    Maria Tereza Azevedo        
             
             
    /s/ Joao Paulo Seibel de Faria   Independent Director   November 12, 2025
    Joao Paulo Seibel de Faria        
             
             

    /s/ Vanessa Claro Lopes

      Independent Director   November 12, 2025
    Vanessa Claro Lopes        
             
             

    /s/ Marcelo Ken Suhara

      Independent Director   November 12, 2025
    Marcelo Ken Suhara        
             
             

    /s/ Miguel Filisbino Pereira de Paula

      Independent Director   November 12, 2025
    Miguel Filisbino Pereira de Paula        

     

     

     

    SIGNATURE OF AUTHORIZED U.S. REPRESENTATIVE OF THE REGISTRANT

     

    Pursuant to the Securities Act, the undersigned, the duly authorized representative in the United States of the registrant has signed this registration statement on the 12th day of November, 2025.

     

      Cogency Global Inc.
    Authorized U.S. Representative
       
         
      By: /s/ Colleen A. De Vries
      Name: Colleen A. De Vries
      Title: Sr. Vice President on behalf of Cogency Global Inc.

     

     

     

    Get the next $AFYA alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AFYA

    DatePrice TargetRatingAnalyst
    9/8/2025$24.50Neutral → Overweight
    Analyst
    9/8/2025$19.00Neutral → Buy
    UBS
    8/6/2025$17.50Underweight → Overweight
    Morgan Stanley
    7/29/2025$14.00Sell → Neutral
    Citigroup
    3/11/2025$19.00 → $17.00Equal-Weight → Underweight
    Morgan Stanley
    1/31/2025$18.00 → $15.00Neutral → Sell
    Citigroup
    12/3/2024$16.00Sell
    Goldman
    8/30/2024$19.50Neutral
    UBS
    More analyst ratings

    $AFYA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Afya Limited Announces Third Quarter and Nine Months 2025 Financial Results

    Impressive Adjusted EBITDA Margin Expansion and Cash Generation Full Year 2025 Guidance Reaffirmed Afya Limited (NASDAQ:AFYA, B3: A2FY34)) ("Afya" or the "Company"), the leading medical education group and medical practice solutions provider in Brazil, reported today its financial and operating results for the three and nine-month period, which ended September 30, 2025 (third quarter 2025). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS). Third Quarter 2025 Highlights 3Q25 Revenue increased 10.4% YoY to R$928.5 million. Revenue excluding acquisitions increased 10.1%, reaching R$926.2 million.

    11/12/25 6:12:00 PM ET
    $AFYA
    Other Consumer Services
    Real Estate

    Afya Limited Announces Medical Seats Increase in AFYA Faculdade de Ciências Médicas Bragança

    Afya Limited (NASDAQ:AFYA, B3: A2FY34)) ("Afya" or the "Company"), the leading medical education group and medical practice solutions provider in Brazil, today announced that the Secretary of Regulation and Supervision of Higher Education of the Ministry of Education ("MEC") authorized the increase of 100 medical seats of ITPAC Porto Nacional – Instituto Tocantinense Presidente Antonio Carlos Porto S.A. (AFYA Faculdade de Ciências Médicas Bragança), in the city of Bragança, located in the state of Pará. With the authorization, Afya reaches 150 medical seats on this campus, and 3,753 total approved seats. This significant presence underscores our commitment to providing quality medical educ

    11/7/25 8:44:00 AM ET
    $AFYA
    Other Consumer Services
    Real Estate

    Repurchase of the Series A Perpetual Convertible Preferred Shares and Repayment of Afya Participações S.A. Debentures

    Afya Limited (NASDAQ:AFYA, B3: A2FY34)) ("Afya" or the "Company"), the leading medical education group and medical practice solutions provider in Brazil, announced today that it has entered into a Share Repurchase Agreement with SBLA Holdco LLC, an affiliate of Softbank, to repurchase all 150,000 Series A Perpetual Convertible Preferred Shares of a nominal or par value of US$0.00005 each in the capital of the Company (the "Series A Preferred Shares") for an aggregate purchase price of R$831.6 million. The transaction is expected to close on November 3, 2025. On April 26, 2021, the Company issued and sold 150,000 Series A Preferred Shares, equivalent to US$150.0 million in Reais, to Softba

    10/22/25 5:01:00 PM ET
    $AFYA
    Other Consumer Services
    Real Estate

    $AFYA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Afya upgraded by Analyst with a new price target

    Analyst upgraded Afya from Neutral to Overweight and set a new price target of $24.50

    9/8/25 8:32:46 AM ET
    $AFYA
    Other Consumer Services
    Real Estate

    Afya upgraded by UBS with a new price target

    UBS upgraded Afya from Neutral to Buy and set a new price target of $19.00

    9/8/25 8:32:46 AM ET
    $AFYA
    Other Consumer Services
    Real Estate

    Afya upgraded by Morgan Stanley with a new price target

    Morgan Stanley upgraded Afya from Underweight to Overweight and set a new price target of $17.50

    8/6/25 7:48:43 AM ET
    $AFYA
    Other Consumer Services
    Real Estate

    $AFYA
    SEC Filings

    View All

    SEC Form S-8 filed by Afya Limited

    S-8 - Afya Ltd (0001771007) (Filer)

    11/12/25 5:26:20 PM ET
    $AFYA
    Other Consumer Services
    Real Estate

    SEC Form 6-K filed by Afya Limited

    6-K - Afya Ltd (0001771007) (Filer)

    11/12/25 4:08:06 PM ET
    $AFYA
    Other Consumer Services
    Real Estate

    SEC Form 6-K filed by Afya Limited

    6-K - Afya Ltd (0001771007) (Filer)

    11/12/25 4:04:37 PM ET
    $AFYA
    Other Consumer Services
    Real Estate

    $AFYA
    Leadership Updates

    Live Leadership Updates

    View All

    Afya Limited Announces Results of Annual General Meeting Held on June 24, 2025

    Afya Limited, or "Afya" (NASDAQ:AFYA) announced today that the resolutions set out in its Notice of Annual General Meeting dated June 9, 2025 was duly passed at its Annual General Meeting held today: (1) the approval and ratification of Afya's financial statements as of and for the fiscal year ended December 31, 2024; (2) the re-appointment of João Paulo Seibel de Faria as an independent director of the Company with immediate effect to hold office for a two year term; (3) the re-appointment of Vanessa Claro Lopes as an independent director of the Company with immediate effect to hold office for a two year term; (4) the re-appointment of Miguel Filisbino Pereira de Paula as an independent di

    6/24/25 5:52:00 PM ET
    $AFYA
    Other Consumer Services
    Real Estate

    Afya Limited Announces that Whitebook was ranked as one of the 10 Top Apps in Brazil by Consumer Spend in 2020

    NOVA LIMA, Brazil and MINAS GERAIS, Brazil, Jan. 15, 2021 (GLOBE NEWSWIRE) -- Afya Limited, or Afya (Nasdaq: AFYA), today announces that its clinical decision software, WhiteBook, an app created by PEBMED, was ranked as one of the 10 Top Apps in Brazil by consumer spend in 2020 for the fifth year in a row. App Annie conducted the study, a website specialized in app analytics and app market data that combined data from iOS and Google Play that evaluates more than 8 million mobile app per year. In the top ten WhiteBook was among great apps such as Tinder, YouTube, Netflix, TikTok and others. Whitebook is a mobile and web application software that helps doctors and medical students to make

    1/15/21 8:55:10 AM ET
    $AFYA
    Other Consumer Services
    Real Estate

    $AFYA
    Financials

    Live finance-specific insights

    View All

    Afya Limited Announces Third Quarter and Nine Months 2025 Financial Results

    Impressive Adjusted EBITDA Margin Expansion and Cash Generation Full Year 2025 Guidance Reaffirmed Afya Limited (NASDAQ:AFYA, B3: A2FY34)) ("Afya" or the "Company"), the leading medical education group and medical practice solutions provider in Brazil, reported today its financial and operating results for the three and nine-month period, which ended September 30, 2025 (third quarter 2025). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS). Third Quarter 2025 Highlights 3Q25 Revenue increased 10.4% YoY to R$928.5 million. Revenue excluding acquisitions increased 10.1%, reaching R$926.2 million.

    11/12/25 6:12:00 PM ET
    $AFYA
    Other Consumer Services
    Real Estate

    Afya Limited Announces Second-Quarter and First-Half 2025 Financial Results

    Impressive Adjusted EBITDA Margin Expansion and Cash Generation Full Year 2025 Guidance Reaffirmed Afya Limited (NASDAQ:AFYA, B3: A2FY34)) ("Afya" or the "Company"), the leading medical education group and medical practice solutions provider in Brazil, reported today its financial and operating results for the three and six-month period, which ended June 30, 2025 (second quarter 2025). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS). Second-Quarter 2025 Highlights 2Q25 Revenue increased 13.5% YoY to R$919.4 million. Revenue excluding acquisitions increased 8.5%, reaching R$879.0 million. 2

    8/13/25 6:03:00 PM ET
    $AFYA
    Other Consumer Services
    Real Estate

    Afya Limited Announces a New Share Repurchase Program

    Afya Limited (NASDAQ:AFYA, B3: A2FY34)) ("Afya" or the "Company"), the leading medical education group and medical practice solutions provider in Brazil, announced today, its Board of Directors has approved a new share repurchase program. Under the share repurchase program, Afya may repurchase up to 4,000,000 of its outstanding Class A common shares, in the open market, based on prevailing market prices, or in privately negotiated transactions, beginning from August 15, 2025 until the earlier of the completion of the repurchase or December 31, 2026, depending upon market conditions. The share purchases may be made from time to time through open market transactions and are subject to marke

    8/13/25 4:48:00 PM ET
    $AFYA
    Other Consumer Services
    Real Estate

    $AFYA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Afya Limited

    SC 13G/A - Afya Ltd (0001771007) (Subject)

    11/14/24 5:15:03 PM ET
    $AFYA
    Other Consumer Services
    Real Estate

    Amendment: SEC Form SC 13G/A filed by Afya Limited

    SC 13G/A - Afya Ltd (0001771007) (Subject)

    11/14/24 4:21:17 PM ET
    $AFYA
    Other Consumer Services
    Real Estate

    Amendment: SEC Form SC 13G/A filed by Afya Limited

    SC 13G/A - Afya Ltd (0001771007) (Subject)

    11/14/24 4:18:15 PM ET
    $AFYA
    Other Consumer Services
    Real Estate